Assist Prof Dr. Wenhao Shen, Urology, Best Researcher Award

Scopus Profile

Bio Summary:

Education:

Dr. Wenhao Shen has an extensive educational background in the field of Urology. Here is a summary of his education experience:

2015: Visiting Scholar

• Institutions: Cleveland Clinic, Cleveland, USA, and Barnes-Jewish Hospital, Washington University in St. Louis, USA.

2006: Ph.D. and M.D. in Urology

• University: Third Military Medical University
• Research Advisor: Professor Bo Song

2003: Master of Medicine in Urology

• University: Third Military Medical University
• Research Advisor: Professor Enqing Xiong

These educational experiences reflect Dr. Wenhao Shen’s commitment to advancing his knowledge and expertise in the field of Urology, showcasing a combination of international exposure and in-depth research guidance from esteemed mentors.

Work Experience:

Dr. Wenhao Shen has gained valuable experience and progressively advanced in his career within the field of Urology. Here is a summary of his work experience:

Director, Associate Professor, Associate Chief Physician

• Department of Urology, Southwest Hospital, Army Medical University (Third Military Medical University)
• Duration: 2022-Present

Associate Director, Associate Professor, Associate Chief Physician

• Department of Urology, Southwest Hospital, Army Medical University (Third Military Medical University)
• Duration: 2018-2022

Associate Professor, Associate Chief Physician

• Department of Urology, Southwest Hospital, Army Medical University (Third Military Medical University)
• Duration: 2013-2017

Lecturer, Attending Physician

• Department of Urology, Southwest Hospital, Army Medical University (Third Military Medical University)
• Duration: 2006-2013

Throughout his career, Dr. Wenhao Shen has consistently contributed to the Department of Urology, showcasing his dedication and expertise in various roles, from a Lecturer and Attending Physician to assuming leadership positions as an Associate Director and Director.

Dr. Wenhao Shen’s research focus includes various aspects of urology, nanomedicine, and targeted drug delivery. His work encompasses both clinical and translational research, aiming to address challenges and advance knowledge in these fields. Some key areas of his research focus include:

In vivo Targeting of Nanoparticles to Prostate Tissues:

• Investigating the capacities of different nanoparticles for in vivo targeting to prostate tissues.
• Utilizing a mouse model of chronic bacterial prostatitis for the study.

Management of Chronic Bacterial Prostatitis:

• Developing antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.
• Exploring innovative approaches for the treatment of urological conditions.

Autoimmune Cystitis and Interstitial Cystitis/Bladder Pain Syndrome:

• Studying the activation of the CXCL13/CXCR5 axis and its role in aggravating experimental autoimmune cystitis.
• Investigating factors contributing to interstitial cystitis/bladder pain syndrome.

Photoselective Sharp Enucleation of the Prostate:

• Introducing innovative surgical techniques for benign prostatic hyperplasia, such as photoselective sharp enucleation using a front-firing 532-nm laser.

Self-Illuminating Triggered Release of Therapeutics:

• Developing nanoprodrugs for the targeted treatment of breast cancer with self-illuminating triggered release mechanisms.

Dr. Shen’s research aims to contribute to advancements in medical treatments, especially in the fields of urology and nanomedicine. His work reflects a multidisciplinary approach, integrating clinical insights with cutting-edge technologies for improved patient outcomes.

Publications Top Noted & Contributions:

Dr. Wenhao Shen has made significant contributions to the field of bioengineering and biotechnology, as evidenced by his publications. Here are some of his recent articles:

Title: In vivo targeting capacities of different nanoparticles to prostate tissues based on a mouse model of chronic bacterial prostatitis

• Authors: Hu, R., Yang, Y., Song, G., … Zheng, J., Shen, W.
• Journal: Frontiers in Bioengineering and Biotechnology, 2022, 10, 1021385
• Citations: 2

Title: Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome

• Authors: Zhao, J., Chen, S., Yang, C., … Yi, S., Dai, S.
• Journal: Biochemical Pharmacology, 2022, 200, 115047
• Citations: 1

Title: Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis

• Authors: Zheng, J., Hu, R., Yang, Y., … Shen, W., Zhou, Z.
• Journal: Acta Biomaterialia, 2022, 143, pp. 471–486
• Citations: 12

Title: Self-Illuminating Triggered Release of Therapeutics from Photocleavable Nanoprodrug for the Targeted Treatment of Breast Cancer

• Authors: Sun, F., Wang, Y., Wang, Q., … Xia, P., Zhang, D.
• Journal: ACS Applied Materials and Interfaces, 2022, 14(7), pp. 8766–8781
• Citations: 6

Title: Photoselective sharp enucleation of the prostate with a front-firing 532-nm laser: an innovative surgical technique for benign prostatic hyperplasia—a single-center study of 475 cases

• Authors: Wang, Y., Liu, Z., Jiang, T., … Zhou, Z., Shen, W.
• Journal: World Journal of Urology, 2021, 39(8), pp. 3025–3033
• Citations: 4

These articles cover a range of topics in urology, nanomedicine, and targeted drug delivery, showcasing Dr. Shen’s diverse and impactful research contributions.